Literature DB >> 21842419

Functional gene expression analysis of tissue-specific isoforms of Mef2c.

Yoshiharu Sekiyama1, Hitoshi Suzuki, Toshifumi Tsukahara.   

Abstract

Mef2c contains three alternative exons and generates six Mef2c isoforms in mice. Mef2c α1β isoforms are expressed in neuronal tissues, α2 isoforms are expressed in muscle, and α1 isoforms are expressed in many other tissues. The γ region inclusion and skipped isoforms are present in equal amounts in many tissues. In this study, differences in the transcriptional activities of each tissue-specific isoform of Mef2c in neuronal cells were examined. Using an MEF2-responsive reporter, exon β-dependent transactivation was found in neuronal cells, as well as in other cell lines previously described. Microarray analysis was used to examine the transcriptional activities of each Mef2c isoform and to assess differences in endogenous gene expression induced by the different isoforms. The results showed significant gene expression changes due to overexpression of Mef2c isoforms in both an isoforms-dependent and -independent manner.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21842419     DOI: 10.1007/s10571-011-9743-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  41 in total

1.  Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.

Authors:  Markus Zweier; Anne Gregor; Christiane Zweier; Hartmut Engels; Heinrich Sticht; Eva Wohlleber; Emilia K Bijlsma; Susan E Holder; Martin Zenker; Eva Rossier; Ute Grasshoff; Diana S Johnson; Lisa Robertson; Helen V Firth; Arif B Ekici; André Reis; Anita Rauch
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

2.  Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family.

Authors:  B L Black; K L Ligon; Y Zhang; E N Olson
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 3.  Basic helix-loop-helix genes in neural development.

Authors:  J E Lee
Journal:  Curr Opin Neurobiol       Date:  1997-02       Impact factor: 6.627

4.  Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.

Authors:  A G Ridgeway; S Wilton; I S Skerjanc
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c.

Authors:  Matthew J Potthoff; Michael A Arnold; John McAnally; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

7.  Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy.

Authors:  Fiona M Menzies; Raphael Hourez; Sara Imarisio; Marcel Raspe; Oana Sadiq; Dhia Chandraratna; Cahir O'Kane; Kenneth L Rock; Eric Reits; Alfred L Goldberg; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-09-09       Impact factor: 6.150

8.  Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.

Authors:  J F Martin; J J Schwarz; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene.

Authors:  F J Naya; C Wu; J A Richardson; P Overbeek; E N Olson
Journal:  Development       Date:  1999-05       Impact factor: 6.868

10.  Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.

Authors:  Jungseog Kang; Christian B Gocke; Hongtao Yu
Journal:  BMC Biochem       Date:  2006-02-14       Impact factor: 4.059

View more
  5 in total

1.  MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.

Authors:  Alex R Paciorkowski; Ryan N Traylor; Jill A Rosenfeld; Jacqueline M Hoover; Catharine J Harris; Susan Winter; Yves Lacassie; Martin Bialer; Allen N Lamb; Roger A Schultz; Elizabeth Berry-Kravis; Brenda E Porter; Marni Falk; Anu Venkat; Rena J Vanzo; Julie S Cohen; Ali Fatemi; William B Dobyns; Lisa G Shaffer; Blake C Ballif; Eric D Marsh
Journal:  Neurogenetics       Date:  2013-02-07       Impact factor: 2.660

2.  MEF2C promotes M1 macrophage polarization and Th1 responses.

Authors:  Xibao Zhao; Qianqian Di; Han Liu; Jiazheng Quan; Jing Ling; Zizhao Zhao; Yue Xiao; Han Wu; Zherui Wu; Wengang Song; Huazhang An; Weilin Chen
Journal:  Cell Mol Immunol       Date:  2022-02-22       Impact factor: 22.096

3.  Epilepsy-causing sequence variations in SIK1 disrupt synaptic activity response gene expression and affect neuronal morphology.

Authors:  Christoph Pröschel; Jeanne N Hansen; Adil Ali; Emily Tuttle; Michelle Lacagnina; Georgia Buscaglia; Marc W Halterman; Alex R Paciorkowski
Journal:  Eur J Hum Genet       Date:  2016-12-14       Impact factor: 4.246

4.  Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia.

Authors:  Ashok Narasimhan; Russell Greiner; Oliver F Bathe; Vickie Baracos; Sambasivarao Damaraju
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-10-06       Impact factor: 12.910

5.  Isoform Specific Effects of Mef2C during Direct Cardiac Reprogramming.

Authors:  Li Wang; Peisen Huang; David Near; Karan Ravi; Yangxi Xu; Jiandong Liu; Li Qian
Journal:  Cells       Date:  2020-01-22       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.